Do omega-3 fatty acids benefit health?
G Curfman - JAMA, 2020 - jamanetwork.com
An important clinical trial of omega-3 fatty acids in patients at high risk of cardiovascular
disease is published in JAMA. 1 In the STRENGTH trial (the Long-Term Outcomes Study to
Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with
Hypertriglyceridemia), 13 078 patients were randomized to receive 4 g/d of a carboxylic acid
formulation of omega-3 fatty acids (a combination of eicosapentaenoic acid [EPA] and
docosahexaenoic acid [DHA]) or corn oil as a comparator. After a median follow-up of 42 …
disease is published in JAMA. 1 In the STRENGTH trial (the Long-Term Outcomes Study to
Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with
Hypertriglyceridemia), 13 078 patients were randomized to receive 4 g/d of a carboxylic acid
formulation of omega-3 fatty acids (a combination of eicosapentaenoic acid [EPA] and
docosahexaenoic acid [DHA]) or corn oil as a comparator. After a median follow-up of 42 …